250 related articles for article (PubMed ID: 16805720)
1. Everolimus: an immunosuppressive agent in transplantation.
Patel JK; Kobashigawa JA
Expert Opin Pharmacother; 2006 Jul; 7(10):1347-55. PubMed ID: 16805720
[TBL] [Abstract][Full Text] [Related]
2. Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction.
Kovarik JM
Drugs Today (Barc); 2004 Feb; 40(2):101-9. PubMed ID: 15045032
[TBL] [Abstract][Full Text] [Related]
3. Review of the proliferation inhibitor everolimus.
Nashan B
Expert Opin Investig Drugs; 2002 Dec; 11(12):1845-57. PubMed ID: 12457444
[TBL] [Abstract][Full Text] [Related]
4. Everolimus: a review of its use in renal and cardiac transplantation.
Dunn C; Croom KF
Drugs; 2006; 66(4):547-70. PubMed ID: 16597167
[TBL] [Abstract][Full Text] [Related]
5. Everolimus in clinical practice--renal transplantation.
Pascual J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
[TBL] [Abstract][Full Text] [Related]
6. Everolimus.
Chapman TM; Perry CM
Drugs; 2004; 64(8):861-72; discussion 873-4. PubMed ID: 15059040
[TBL] [Abstract][Full Text] [Related]
7. Proliferation signal inhibitors in cardiac transplantation.
Gustafsson F; Ross HJ
Curr Opin Cardiol; 2007 Mar; 22(2):111-6. PubMed ID: 17284989
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the immunosuppressive regimen in heart transplantation.
Eisen H; Ross H
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
[TBL] [Abstract][Full Text] [Related]
9. Everolimus in liver and lung transplantation.
Koch M
Drugs Today (Barc); 2009 Jan; 45(1):11-20. PubMed ID: 19271028
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.
Ettenger RB; Grimm EM
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S22-8. PubMed ID: 11583941
[TBL] [Abstract][Full Text] [Related]
11. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
[TBL] [Abstract][Full Text] [Related]
12. Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments.
Neumayer HH
Transplantation; 2005 May; 79(9 Suppl):S72-5. PubMed ID: 15880019
[TBL] [Abstract][Full Text] [Related]
13. Everolimus: efficacy and safety in cardiac transplantation.
Schaffer SA; Ross HJ
Expert Opin Drug Saf; 2010 Sep; 9(5):843-54. PubMed ID: 20701555
[TBL] [Abstract][Full Text] [Related]
14. Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
Sánchez-Fructuoso AI
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):807-19. PubMed ID: 18611120
[TBL] [Abstract][Full Text] [Related]
15. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
Valantine H; Zuckermann A
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
[TBL] [Abstract][Full Text] [Related]
16. Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
Eisen H
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii9-13. PubMed ID: 16815858
[TBL] [Abstract][Full Text] [Related]
17. Experience with everolimus.
Augustine JJ; Hricik DE
Transplant Proc; 2004 Mar; 36(2 Suppl):500S-503S. PubMed ID: 15041396
[TBL] [Abstract][Full Text] [Related]
18. Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.
Gabardi S; Baroletti SA
Pharmacotherapy; 2010 Oct; 30(10):1044-56. PubMed ID: 20874042
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of everolimus in chronic allograft nephropathy.
Das U; Dakshinamurty KV
Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):910-6. PubMed ID: 24029254
[TBL] [Abstract][Full Text] [Related]
20. Concentration-controlled everolimus (Certican): combination with reduced dose calcineurin inhibitors.
Pascual J
Transplantation; 2005 May; 79(9 Suppl):S76-9. PubMed ID: 15880020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]